Skip to main content

Table 2 Instruments used the INDDEP study

From: The INDDEP study: inpatient and day hospital treatment for depression – symptom course and predictors of change

Time point of measurement Outcome/Variables Patient Research assistant
   (self-report) (expert rating)
T0 (admission) Depressive symptomatology: QIDS-SR QIDS-C, SKID-I
Co-morbidity   SCID I + II
Personality, interpersonal problems, mode of coping: IIP-32, DEQ, DAS  
Overall disturbance and functioning: SCL-90-R SOFAS
Social support: F-SozU K-14  
Quality of Life: SF-12  
  Traumatisation: CTQ  
T1 (discharge)   QIDS-SR QIDS-C
   SCL-90-R SOFAS
   IIP-32  
T2 (3-months Follow-up) and T3 (12-months Follow-up)   QIDS-SR QIDS-C, LIFE-Interview
SCL-90-R SOFAS
SF-12  
   IIP-32  
  1. QIDS-SR = Quick Inventory of Depressive Symptoms, self-report form [23], QIDS-C = expert rating; SCID-I and SCID-II=Structured Clinical Interview for DSM IV axis I and II [24, 25]; SCL-90-R = Symptom-Check-List 90-R [26]; DAS = Dysfunctional Attitudes Scale [27, 28]; DEQ = Depressive Experiences Questionnaire [29, 30]; SOFAS = Social and Occupational Functioning Assessment Scale [31]; IIP-32 = Inventory of Interpersonal Problems, 32-item version [32, 33]; F-SozU K-14 = Fragebogen zur sozialen Unterstützung, 14-item version [34]; SF-12 = Fragebogen zum Gesundheitszustand (quality of life) [35]; CTQ = Childhood Trauma Questionnaire [36, 37]; LIFE-Interview = Longitudinal Interval Follow-up Evaluation [38].
  2. Note: Additionally assessed at all time points of measurement: pharmacological treatment, somatic diagnoses; at T0: previous treatment for depression; at T1: documentation of treatment received (dose, components); T2 and T3: further outpatient treatment, days of sick leave, number of contacts to health care system.